Skip to main content

Advertisement

SpringerLink
Log in

Is There a Role for Surgery in Recurrent Gastric Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ajani JA. Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen. Cancer. 2008;113(5):945–55. Review.

    Article  PubMed  CAS  Google Scholar 

  2. Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol. 2005;2:98–107.

    Article  PubMed  Google Scholar 

  3. Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol. 1999; 6:46–56.

    Article  PubMed  CAS  Google Scholar 

  4. Badgwell B, Cormier JN, Xing Y, Yao J, Bose D, Krishnan S, et al. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol. 2009;16(1):42–50.

    Google Scholar 

  5. Roukos DH. Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol. 2004; 11:127–9.

    Article  PubMed  Google Scholar 

  6. Roukos DH, Hottenrott C, Encke A, Baltogiannis G, Casioumis D. Primary gastric lymphomas: a clinicopathologic study with literature review. Surg Oncol. 1994;3(2):115–25.

    Article  PubMed  CAS  Google Scholar 

  7. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. for Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.

    Article  PubMed  CAS  Google Scholar 

  8. Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery. 1998;123(5):573–8.

    Article  PubMed  CAS  Google Scholar 

  9. Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002;9(9):828–30.

    Article  PubMed  Google Scholar 

  10. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.

    Article  PubMed  CAS  Google Scholar 

  11. Briasoulis E, Fatouros M, Roukos DH. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol. 2007;14:2691–5.

    Article  PubMed  Google Scholar 

  12. Roukos DH. Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol. 2002;9:220–1.

    Article  PubMed  Google Scholar 

  13. Briasoulis E, Liakakos T, Dova L, Fatouros M, Tsekeris P, Roukos DH, et al. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Rev Anticancer Ther. 2006;6:931–9.

    Article  PubMed  Google Scholar 

  14. Liakakos T, Roukos DH. More controversy than ever - challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15(4):956–60.

    Article  PubMed  Google Scholar 

  15. Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–141.

    Article  PubMed  Google Scholar 

  16. Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15(1):21–33.

    Article  PubMed  Google Scholar 

  17. Roukos DH, Kappas AM, Agnantis NJ. Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol. 2003;10:718–21.

    Article  PubMed  Google Scholar 

  18. Fatouros M, Roukos DH, Arampatzis I, Sotiriadis A, Paraskevaidis E, Kappas AM. Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther. 2005;5(4):737–45.

    Article  PubMed  Google Scholar 

  19. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247(4):714–5.

    Article  PubMed  Google Scholar 

  20. Roukos DH. Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med. 2007;357(15):1555–6; author reply 1556.

    Article  PubMed  CAS  Google Scholar 

  21. Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008 10;358(15):1636; author reply 1636.

    Google Scholar 

  22. Roukos DH. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9(1):1–6.

    Google Scholar 

  23. Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26(26):4360–1.

    Article  PubMed  Google Scholar 

  24. Roukos DH. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med. 2008;358:197, author reply 198.

    Article  PubMed  CAS  Google Scholar 

  25. Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn. 2008;8(1):29–39.

    Article  PubMed  CAS  Google Scholar 

  26. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587–97.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Department of Surgery, University of Ioannina, Ioannina, Greece

    C. Bali MD, D. Ziogas MD, E. Fatouros MD & M. Fatouros MD

Authors
  1. C. Bali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Ziogas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Fatouros MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Fatouros MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Ziogas MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bali, C., Ziogas, D., Fatouros, E. et al. Is There a Role for Surgery in Recurrent Gastric Cancer. Ann Surg Oncol 16, 1074–1075 (2009). https://doi.org/10.1245/s10434-008-0302-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0302-7

Keywords

Search

Navigation